Obesity and liver disease: the epidemic of the twenty-first century.
about
Outcomes of abdominal surgery in patients with liver cirrhosisThe Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver DiseaseThe Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in MiceNoninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.The Effect of Chlorella vulgaris Supplementation on Liver En-zymes, Serum Glucose and Lipid Profile in Patients with Non-Alcoholic Fatty Liver DiseaseThe promise of metabolic phenotyping in gastroenterology and hepatology.Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchPiceatannol Exerts Anti-Obesity Effects in C57BL/6 Mice through Modulating Adipogenic Proteins and Gut Microbiota.Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.The rationale for targeting TGF-β in chronic liver diseases.The prevalence of overweight/obesity in high school adolescents in Jeddah and the association of obesity association with dental caries.Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis.Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.Toward the Effective Co-management of Patients with Cirrhosis by Primary Care Providers and Specialists.Live cell imaging of cytosolic NADH/NAD+ ratio in hepatocytes and liver slices.Viewpoint: A Contributory Role of Shell Ginger (Alpinia zerumbet (Pers.) B.L. Burtt & R.M. Sm) for Human Longevity in Okinawa, Japan?Bile acids as global regulators of hepatic nutrient metabolism
P2860
Q26766070-B9ACE2F5-52E6-4438-8974-F484177286E8Q26798153-0D98B787-C7A9-4AAE-8E8D-06D9B938D9C8Q28552063-7DC062B5-732F-4214-96C0-286B7707854AQ30249400-6B9DB292-480A-4ADD-B1E2-1BB4F114E7FDQ34003370-758E9929-5EFA-4C58-8242-9A4BA8D6FA2AQ35701279-D2F7F62A-BA9A-4962-8A1A-4DFD0AA0B6F9Q35899644-222AE1D9-58DC-48CA-86E1-EFAB7258E39CQ36129673-CB6AC38D-783A-4095-A249-5BADC8179C51Q36176999-CED5D961-2C87-46F4-8661-284F7F96210FQ37146192-4EAC449C-A517-48DF-93D2-473A34ED96D7Q38665591-A7F628BD-110F-45CF-B3DE-D7183FD17680Q38715538-62CAEBFB-A8F9-465A-A0B4-8E7D68363280Q38854536-5E7810D9-DE3F-49AF-AF61-0D0598554F27Q41991379-E6C8BFC5-6930-40A5-99FA-58A3A736A694Q43635935-0ED97EDD-3EE4-4BFC-83C1-DEB57BFECBF3Q46109785-1176A9A2-AD3A-4B4C-BCFC-DC65C9A37247Q46207504-A0266353-C5BA-4DC3-A9DC-3D1C9ADB6E9AQ47615003-A38F1A0E-F0A4-40BB-83A2-01B1C4B4B1AFQ49555913-4FAFBCDB-31BD-49B8-8D74-F5C2DA8BB893Q57128749-F5FD76B8-7E5D-4773-82E7-F8B4D692CC3F
P2860
Obesity and liver disease: the epidemic of the twenty-first century.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Obesity and liver disease: the epidemic of the twenty-first century.
@ast
Obesity and liver disease: the epidemic of the twenty-first century.
@en
type
label
Obesity and liver disease: the epidemic of the twenty-first century.
@ast
Obesity and liver disease: the epidemic of the twenty-first century.
@en
prefLabel
Obesity and liver disease: the epidemic of the twenty-first century.
@ast
Obesity and liver disease: the epidemic of the twenty-first century.
@en
P1476
Obesity and liver disease: the epidemic of the twenty-first century.
@en
P2093
Kathleen E Corey
Lee M Kaplan
P356
10.1016/J.CLD.2013.09.019
P577
2014-02-01T00:00:00Z